Introduction
In the absence of extracellular growth factors, most untransformed mammalian cells fail to proliferate and withdraw from the cell cycle into a resting state, termed G 0 . Such quiescent cells can be induced to exit G 0 and recommence proliferation by stimulation of a variety of growth factor-dependent signal transduction pathways, acting in a combinatorial and synergistic manner (Rozengurt, 1986 (Rozengurt, , 1992 . The murine Swiss 3T3 cell line has provided a useful system in which to characterise such mitogenic signal transduction cascades. Stimulation of quiescent cultures of these cells by either phorbol ester-mediated protein kinase C (PKC) activation, cAMP-mediated protein kinase A (PKA) activation or by insulin is not sucient to promote reinitiation of DNA synthesis. However, any combination of these signals can induce quiescent Swiss 3T3 cells to exit G 0 and re-enter the cell cycle (Albert and Rozengurt, 1992; Withers et al., 1995; Seuerlein et al., 1996) . The neuropeptide bombesin, which activates multiple second messenger pathways in these cells (Rozengurt, 1995) , can induce a proliferative response in the absence of any other exogenously added signal but its mitogenic eect is markedly potentiated by the addition of insulin (Rozengurt and Sinnett-Smith, 1983) . Because all these distinct stimuli induce DNA synthesis, they must coverge prior to S phase of the cell cycle but the precise point of convergence and integration in G 1 is unknown. At least two alternative models can be envisaged: mitogenic signals could converge rapidly into a common pathway leading to DNA synthesis or they could remain distinct throughout most of G 1 and only converge at the G 1 /S boundary.
The transit through mid/late G1 and entry into S phase of the cell cycle is regulated by the activity of the cyclin-dependent kinases (cdks) (reviewed in: Sherr and Roberts, 1995; Weinberg, 1995; Bartek et al., 1996) . The D-type cyclins and cyclin E accumulate sequentially during mid/late G 1 , forming complexes with cdk4 and cdk6 and with cdk2 respectively (Matsushime et al., 1991 (Matsushime et al., , 1992 Ko et al., 1992; Bates et al., 1994; Meyerson and Harlow, 1994) . These cyclin/cdk holoenzymes play a vital role in the positive regulation of S phase entry. Over-expression of either cyclin D1 or E has been shown to reduce the time required to traverse G 1 , accelerating S phase entry (Ohtsubo and Roberts, 1993; Quelle et al., 1993; Musgrove et al., 1994; Resnitzky et al., 1994; Wimmel et al., 1994) . The action of the G 1 cdks is constrained by at least two families of cdk inhibitors: the p16 Ink4a class, which speci®cally inhibit the catalytic partners of the D-type cyclins (Serrano et al., 1993; Hannon and Beach, 1994; Hirai et al., 1995; Parry et al., 1995) , and the p21 Cip1 / p27
Kip1 family, members of which display broader speci®city in cdk inhibition (Xiong et al., 1993; Toyoshima and Hunter, 1994; Harper et al., 1995; Lee et al., 1995) . p27
Kip1 has been strongly implicated in the mitogen-dependent regulation of the cdks, accumulating in quiescent cells and being down-regulated when cells are induced to proliferate (Sherr and Roberts, 1995; Rivard et al., 1996) .
The diverse array of mitogenic signals which are able to stimulate quiescent cells to proliferate must modulate the activities of these key mediators of cell cycle control. Indeed, a number of studies using a variety of cell lines have demonstrated that changes in the levels of the G 1 -speci®c cyclins and the cdk inhibitor p27
Kip1 occur when quiescent cells are stimulated with either whole serum, platelet-poor plasma or de®ned growth factors such as EGF, IFG-1, PDGF or TGF-b (Won et al., 1992; Winston and Pledger, 1993; Polyak et al., 1994; Agrawal et al., 1996; Ravitz et al., 1996; Rivard et al., 1996; Winston et al., 1996) . Each of these factors can activate a variety of intracellular signal transduction pathways so that the point of convergence of mitogenic signalling remains unclear.
If mitogenic signals converge rapidly into a common pathway, dierent stimuli would be expected to elicit identical changes in the expression and activity of these cell cycle regulators. Alternatively, if mitogenic signals act via distinct pathways throughout G 1 , each pathway may evoke a dierent pattern of cyclin, cdk and inhibitor expression. The experiments presented here were designed to distinguish between these alternative models of the convergence and integration of mitogenic signalling by analysing the changes in the key elements of the regulatory machinery of the cell cycle in response to dierent mitogenic signals in Swiss 3T3 cells. Our results demonstrate that the activation of distinct signalling pathways leads to dierential regulation of the levels of the cell cycle regulatory components and consequently support a model in which mitogenic pathways remain distinct throughout G 1 .
Results

pRb phosphorylation in response to various mitogenic signals
Quiescent Swiss 3T3 cells can be induced to exit G 0 and progress into S phase by activation of either PKA or PKC in the presence of insulin or by stimulation with bombesin either in the presence or absence of insulin (Withers et al., 1995; Seuerlein et al., 1996) . At the molecular level, one event which has been consistently observed to precede S phase entry is hyperphosphorylation of pRb. We ®rst addressed whether the distinct signalling pathways converged prior to pRb hyperphosphorylation. Quiescent Swiss 3T3 cells were transferred to media containing the PKC-activator PDB, the cAMP-elevating agents forskolin and IBMX or the neuropeptide bombesin, either in the absence or in the presence of insulin. Following stimulation, cells were harvested at 3 h intervals from 0 ± 24 h. Extracts were prepared and immunoblotting was performed using a pRb-speci®c antiserum, pRb hyperphosphorylation being assessed by the appearance of more slowly migrating pRb species. Stimulation of quiescent cells with bombesin/insulin, PDB/insulin or forskolin/ insulin caused the initial appearance of pRb hyperphosphorylation 15 h after treatment, whilst bombesin alone ®rst caused hyperphosphorylation of pRb after 21 h (Figure 1 ). In each case, the appearance of slowly migrating forms of pRb correlated with the ability of the mitogens to subsequently induce DNA synthesis (Withers et al., 1995; Seuerlein et al., 1996; see Figure  2 ). The delay in bombesin-induced pRb hyperphosphorylation correlated with a slower commencement of DNA synthesis (results not shown). Taken together, these results indicate that the dierent mitogenic signalling pathways converge at a point prior to pRb phosphorylation in Swiss 3T3 cells.
Eect of various mitogens on the expression of the G 1 cyclins, cdks and inhibitors
We next examined the changes in the levels of the G 1 cyclins induced by dierent mitogenic signals, using Western blotting of extracts from cells stimulated for 14 h by the indicated agents (Figure 2 ). Parallel cultures were maximally stimulated with serum. We again measured pRb phosphorylation by Western blotting and DNA synthesis by [ 3 H]thymidine incorporation to assess the ability of each treatment to elicit cell cycle reentry. In the presence of insulin, treatment with bombesin, or activation of PKC or PKA all caused pRb hyperphosphorylation and [ 3 H]thymidine incorporation to similar levels as those achieved by serum (Figure 2a ). Hyperphosphorylation of pRb was barely detectable in cells treated with bombesin alone after 14 h, although this neuropeptide did cause a signi®cant increase in DNA synthesis measured after 40 h ( Figure  2a ). However, this observation re¯ects the kinetics of the bombesin response since cells that had been stimulated for 21 h with bombesin alone showed similar levels of pRb hyperphosphorylation to cells stimulated for 15 ± 18 h with bombesin plus insulin (see Figure 1) . Cyclin D1 protein expression was induced by bombesin, bombesin/insulin and PDB/insulin, typically resulting in an eight-, 12-and 25-fold increase in the level of this cyclin, respectively, over that found in unstimulated cells. In striking contrast, the mitogenic combination of forskolin/insulin induced only slightly greater levels of cyclin D1 (®vefold induction) than produced by either insulin or phorbol esters alone (fourfold induction), neither of which is mitogenic for Swiss 3T3 cells. Cyclin D3 protein expression was less dramatically aected by these mitogens, exhibiting only a two-to fourfold induction in levels over untreated cells. Unlike cyclin D1, cyclin D3 protein levels were most elevated in the presence of forskolin/insulin relative to levels produced by either bombesin/insulin or PDB/insulin. Induction of cyclin E protein by the agents which promoted DNA synthesis was also less pronounced than that of cyclin D1, being elevated between four-and sevenfold by each of the mitogens The activities of the G 1 -speci®c cyclin/cdk complexes are constrained by the presence of inhibitor subunits. p16
Ink4a
, which is speci®c for the catalytic partners of the D-type cyclins, was present at a constant level in each case either before or after stimulation ( Figure 2d ). In contrast, p21
Cip1 and p27
Kip1
, which inhibit all the G 1 cyclin/cdk combinations, showed dramatic and opposing changes in their levels. p27
Kip1 levels were generally decreased in response to mitogenic treatments ( Figure  2d ). PDB/insulin caused a 50% decrease in the level of p27 Kip1 relative to unstimulated cells whilst forskolin/ insulin lead to a signi®cantly greater decline in p27 Kip1 protein levels, such that the level of p27
Kip1 detected was only 5 ± 10% of that in unstimulated cells. After 14 h of stimulation of quiescent Swiss 3T3 cells with bombesin alone, p27
Kip1 protein levels were reduced to about 60% of the unstimulated values. Interestingly, insulin alone reproducibly caused an approximate doubling of p27 Kip1 protein levels. However, the combination of bombesin and insulin exhibited a dramatic synergy in promoting p27
Kip1 down-regulation, with p27
Kip1 protein being almost undetectable (Figure 2d ). Serum stimulation had little eect on p27
Kip1 protein levels, as has been previously reported (Toyoshima and Hunter, 1994) .
In contrast to p27 Kip1 , p21 Cip1 was found to increase markedly in cells which had been exposed to agents that result in S phase entry whilst quiescent cells had low levels of p21 Cip1 (Figure 2d ). Thus, we observed an apparent paradox where an inhibitor of proliferation (p21 Cip1 ) was found in greater abundance in cells undergoing the G 1 /S transition than in quiescent cells. The elevated levels of p21
Cip1 in Swiss 3T3 cells are clearly insucient to fully inhibit G 1 cyclin/cdk activity (see Figure 5 ) and may indicate an alternative role for the p21
Cip1 protein such as an assembly factor for cyclin/ cdk holoenzymes. Similar increases in the level of p21
Cip1 have been observed in other systems Li et al., 1994; Nourse et al., 1994; Sheikh et al., 1994) .
Eect of stimulation of PKC or PKA by other agents
To further substantiate the observations presented in Figure 2 , we examined the eects of other mitogens which activate the same pathways as forskolin or PDB. To activate PKC we employed a second phorbol ester, TPA, and we mimicked forskolin by directly elevating the level of intracellular cAMP using the nonhydrolysable, cell permeable analogue, 8-bromocAMP. Treatment of quiescent Swiss 3T3 cells with 8-bromo-cAMP and insulin caused changes analogous to those observed with forskolin/insulin: an increase in the level of cyclin D3, a striking decline in the level of p27
Kip1 and little increase in cyclin D1 levels relative to treatment with insulin alone (Figure 3) . Also, TPA/ insulin caused identical alterations to PDB/insulin, with a marked elevation in the cyclin D1 level and more modest changes in the levels of cyclin D3 and p27 Kip1 ( Figure 3) . The results presented in Figures 2 and 3 indicate that, in the presence of insulin, activation of the PKC signal transduction pathway elicited a pattern of expression of the cell cycle components that was clearly distinguishable from that induced through activation of the PKA pathway, though both pathways promoted similar levels of DNA synthesis.
We also performed additional controls to ensure that the changes we were observing in the levels of the cyclins and the cdk inhibitors were not simply due to kinetic variations in the responses to the dierent treatments (although this seemed unlikely given the pRb phosphorylation data shown in Figure 1 ). Time course analysis of the expression of cyclins D1 and D3 and the cdk inhibitor p27
Kip1 in response to PDB/ insulin and forskolin/insulin showed that the levels measured after 14 h (Figures 2 and 3 ) re¯ected a genuine dierence in response to these two mitogenic combinations (Figure 4 ). , although they did so in dierent ways. In the presence of insulin, PKA activation greatly reduced p27
Kip1 levels but had a modest eect on total cyclin D levels whilst the opposite was true for PKC stimulation. Cyclin E levels were induced to similar extents by all mitogenic treatments. These data predict that the mitogens would cause elevations in the levels of G 1 cyclin/cdk complexes free from the constraining in¯uence of the p27
Kip1 inhibitor and hence that the kinase activity of these complexes would be increased.
To test this prediction, we stimulated quiescent Swiss 3T3 cells and measured the activity cyclin/cdk holoenzymes directly by immunoprecipitation of complexes through the cdk subunit followed by assay of kinase activity. cdk4 immunoprecipitates were assayed against pRb whilst cdk2 assays were performed using histone H1 as the substrate. Immunoprecipitation through cdk2 following 14 h of stimulation (when cyclin A was not detectable by immunoblot analysis) essentially measured the activity of the cyclin E/cdk2 complexes. Figure 5 shows the results of typical assays. Following treatment of Swiss 3T3 cells with any mitogenic combination of agents, a substantial increase in immunoprecipitable kinase activty was detectable for both cdk4 and cdk2. These results corroborated our Western analysis since we had observed that forskolin/insulin was less eective than PDB/insulin in terms of elevating total cyclin D levels but more eective at reducing p27 Kip1 levels (Figures 2  and 3) . Forskolin or PDB when combined with insulin were approximately equally eective at inducing DNA synthesis. Thus, the mitogenic signalling from both agents resulted in similar net gain in cdk4 activity (although this was achieved by distinct mechanisms) and similar increases in the levels of DNA synthesis.
Interestingly, although the combination of bombesin and insulin both elevated levels of cyclin D1 and greatly suppressed the levels of p27 Kip1 , the levels of cdk4 activity detected was similar to that obtained with other treatments. Therefore, it appears that not all of the increase in the cyclin D : p27
Kip1 ratio caused by treatment with bombesin and insulin is manifest as elevated kinase activity. This may be related to the three-or ®vefold greater level of p21
Cip1 found in cells treated with bombesin/insulin compared to that found in cells treated with either PDB/insulin or forskolin/ insulin (see Figure 2d) . When used alone, bombesin caused no detectable increase in cdk4 activity 14 h after stimulation although, as with the lack of pRb hyperphosphorylation at this time, this is likely to re¯ect the slower kinetics of this response. It is noteworthy however that a small but signi®cant amount of cdk2 activity was detectable 14 h after bombesin stimulation.
Eect of stimulation of various mitogenic signalling pathways on mRNA levels of the cell cycle components
In order to gain insights into the mechanisms involved, we next examined the eect of the dierent mitogens on mRNA levels of p27
Kip1 and cyclins D1 and D3, the three components which showed greatest variability in expression after activation of various signalling pathways ( Figure 6 ). Cyclin D1 and D3 mRNA levels were induced in each case where an increase in protein was observed, although stimulation with bombesin alone appeared to induce slightly less cyclin D1 mRNA and more cyclin D3 mRNA than may be anticipated from the protein levels observed (Figure 2 ). p27
Kip1 mRNA levels were largely unaltered by the various stimuli except in two cases. p27
Kip1 mRNA levels were suppressed by bombesin/insulin, but elevated by activation of PKA signalling. These data further demonstrate alternative routes to mitogenesis, with bombesin/insulin reducing p27
Kip1 levels via a transcriptional mechanism whilst forskolin/insulin acted via post-transcriptional mechanisms on p27
Kip1 abundance.
Discussion
It is increasingly recognized that the transition of quiescent cells to S phase of the cell cycle can be induced by multiple parallel pathways that act in a combinatorial and synergistic manner (Rozengurt, 1986 (Rozengurt, , 1992 . Although these mitogenic pathways must converge prior to the onset of DNA replication, the precise point of convergence and integration has not been elucidated. It is also known that the regulation of the activity of cdks in mid/late G 1 plays a central role in promoting entry into S phase (Sherr and Roberts, 1995; Weinberg, 1995; Bartek et al., 1996) . In this context, at least two alternative models of the convergence of mitogenic signalling can be envisaged. Firstly, if the signal transduction pathways converge rapidly after their initial stimulation into a common pathway to cause proliferation diverse stimuli should evoke an identical pattern of expression of the regulators of the cell cycle. Alternatively if diverse signalling pathways remain distinct throughout G 1 , each pathway should induce a unique pro®le of expression of the cyclins, cdks and inhibitors.
In the present study we have demonstrated that addition of bombesin with or without insulin, or activation of either PKC or PKA in combination with insulin, all induced the hyperphosphorylation of Figure 5 Con¯uent and quiescent cultures of Swiss 3T3 cells in 100 mm dishes were washed and incubated at 378C in 10 ml of DMEM/Weymouth's medium containing the indicated agents as described in Materials and methods. After 14 h, cells were washed and lysed. The lysate from one dish was immunoprecipitated for either cdk4 or cdk2. Immunoprecipitates were washed and assayed for kinase activity, cdk4 being assayed against pRb (a) and cdk2 against histone H1 (b). The products of the kinase reactions were resolved by SDS ± PAGE and quanti®ed via the Molecular Dynamics Phosphorimager. Results shown are the means of duplicate assays, corrected for non-speci®c [ Con¯uent and quiescent cultures of Swiss 3T3 cells in 100 mm dishes were washed and incubated at 378C in 10 ml of DMEM/Weymouth's medium containing the indicated agents as described in Materials and methods. After 14 h, cells were washed, lysed and RNA isolated. Northern blotting was performed as described in Materials and methods. The variation in migration observed in some cyclin D1 and p27
Kip1 mRNA samples was not reproducibly detected pRb (and subsequently caused DNA synthesis), indicating that convergence of the signalling pathways occurred before this event. Data from a number of systems has indicated that pRb hyperphosphorylation is achieved by a combination of the activities of the G 1 cyclin/cdks (reviewed in Weinberg, 1995; Bartek et al., 1996) . These cdks are regulated, at least in part, by the periodic association with the activating cyclin subunits (D-type cyclins and cyclin E) and by the levels of the constraining inhibitor proteins (principally p27
Kip1
). Over-expression of D cyclins can reduce the time required to traverse G 1 and enter S phase (Quelle et al., 1993; Resnitzky et al., 1994; Musgrove et al., 1994) , whereas over-expression of p27
Kip1 can cause cell cycle arrest Toyoshima and Hunter, 1994) . Thus, mitogens would be expected to elevate the ratio of D-type cyclin : p27 Kip1 thereby providing conditions favourable for entry into S phase of the cell cycle.
Our results demonstrate that stimuli that elicited DNA synthesis in quiescent Swiss 3T3 cells all increased the ratio of cyclin D : p27 Kip1 , but, crucially, they did so through dierent mechanisms: in the presence of insulin, activators of PKC raised cyclin D1 levels, activators of PKA reduced p27
Kip1 levels and elevated cyclin D3 levels (Figures 2 and 3) whilst binding of bombesin to its G protein-coupled receptor caused an increase in the cyclin D1 level and a striking reduction in the content of p27 Kip1 (Figure 2d) . Results from the immunoprecipitation kinase assays clearly demonstrated that these alterations in the cyclin D : p27 Kip1 ratio were re¯ected by the levels of cyclin D-associated kinase activity in these cells (Figure 5a ). Each of these mitogenic combinations also elevated cyclin E and the activity of cdk2 in immunoprecipitations (Figure 5b) .
Thus, our results demonstrate that dierent signal transduction pathways that promote entry into S phase of the cell cycle elicit distinct patterns of expression of cyclins and inhibitor proteins in vivo. This outcome is incompatible with the common route to proliferation but favours a model in which each mitogenic signalling pathway acts independently, converging only at the level of the machinery that regulates entry into S phase of the cell cycle.
Recently, studies analysing the expression of human cyclin D1 gene have demonstrated the involvement of the MAPK cascade as a positive mediator of growth factor signalling to its promoter (Albanese et al., 1995; Lavoie et al., 1996) . Our results are in agreement with these studies. Thus, stimulation of quiescent Swiss 3T3 cells with insulin and either bombesin or PDB caused a dramatic increase in the level of cyclin D1 mRNA and protein and have been previously been shown to lead a potent and persistent activation of the p42 and p44 MAPKs (Seuerlein et al., 1996) . In contrast, PKA activation by either forskolin or 8-bromo-cAMP did not stimulate the components of the Raf/MEK/MAPK cascade in these cells (Withers et al., 1995) and do not lead to elevated cyclin D1 levels (Figure 2) . Interestingly, however, PKA activation in the presence of insulin increased expression of cyclin D3. This suggests that the mitogenic induction of cyclin D3 is indepdendent of MAPK stimulation and that the two D type cyclins expressed in Swiss 3T3 cells are regulated in a non-co-ordinate manner.
Although p27
Kip1 levels are little altered when quiescent Swiss 3T3 cells are stimulated with whole serum (Toyoshima and Hunter, 1994 ; this study, Figure 2d ) we detected signi®cant down-regulation of this cdk inhibitor protein following mitogenic stimulation with either bombesin or cAMP-elevating agents in the presence of insulin. In addition, these two mitogenic combinations appeared to act at dierent levels: bombesin/insulin reduced the level of p27 Kip1 mRNA whereas forskolin/insulin actually increased p27
Kip1 mRNA levels but reduced the cellular level of inhibitor protein. Elevations of intracelular cAMP have been shown to lead to increased levels of p27
Kip1 in macrophages and T cells Slingerland et al., 1994; Nourse et al., 1994) . The increase in p27 Kip1 mRNA levels after stimulation of PKA signalling may indicate that part of this mechanism is operative in Swiss 3T3 cells, although the cells do not arrest in G 1 because the increase in p27
Kip1 mRNA is not re¯ected in increased levels of inhibitor protein (Figures 2 and 3) . The post-transcriptional regulation of p27
Kip1 levels by PKA and insulin in Swiss 3T3 cells may occur at either of the levels previously reported, that is, via ubiquitin-mediated proteolysis (Pagano et al., 1995) or translational eciency (Hengst and Reed, 1996) .
Whilst this manuscript was in preparation, reported results which also indicate that distinct mitogenic signalling pathways converge at the level of the cyclin D/cdk/pRb cell cycle checkpoint. They demonstrated that mitogenic signalling through three distinct cell surface receptors (the G-proteincoupled thyrotropin receptor, the EGF receptor tyrosine kinase and the oestrogen receptor) were all susceptible to inhibition by microinjection of the cdk4/ 6 inhibitor p16
Ink4
. Thus, each of these pathways requires the activation of cyclin D-dependent kinases in order to elicit S phase entry. Our results not only agree with this conclusion but also demonstrate that the stimulation of distinct mitogenic signalling pathways leads to dierential eects on the levels of the key regulators of the cell cycle, namely the cyclins and the cdk inhibitor p27 Kip1 . Our ®ndings indicate that diverse mitogenic signalling pathways act in parallel throughout most of G 1 , converging at the level of the machinery that regulates entry into S phase of the cell cycle.
Materials and methods
All materials were obtained from Sigma unless otherwise speci®ed. The anti-pRb antibody was from Pharmingen, USA. Antibodies against p27
Kip1 (sc-528, sc-527), cyclin D3 (sc-182), cyclin E (sc-481), cdK4 (sc-260) and cdk6 (sc-177) were from Santa Cruz Biotechnology Inc., USA. The anticdk2 antibody (06 ± 148) was from Upstate Biotechnology Inc., USA. Anti-cyclin D1 and anti-p16
Ink4a antibodies were kind gifts from Dr G Peters, Imperial Cancer Research Fund and the anti-p21
Cip1 antibody was a kind gift from Dr X Lu, Ludwig Institute for Cancer Research. ECL reagent and all radiolabelled compounds were obtained from Amersham, UK.
Swiss 3T3 cells were maintained in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 10% foetal bovine serum (FBS) in a humidi®ed atmosphere containing 10% carbon dioxide and 90% air at 378C. For experimental purposes, cells were plated in 100 mm Nunc petri dishes 6610 5 cells per dish in DMEM supplemented with 10% FBS and allowed to quiesce over the following 6 ± 8 days.
Con¯uent and quiescent cultures of Swiss 3T3 cells were washed twice with DMEM and incubated in DMEM/ Weymouth's medium (1 : 1 vol : vol) containing supplements as appropriate at the following concentrations: insulin, 1 mg/ ml; bombesin, 10 nM; forskolin, 10 mM; 3-isobutyl-1-methylxanthine (IBMX), 50 mM; phorbol-12,13-dibutyrate (PDB), 100 nM; phorbol-12,13,20-triacetate (TPA), 100 nM; 8-bromocAMP, 2.5 mM.
DNA synthesis was measured following the incorporation of [ 3 H]thymidine into acid insoluble material. Cells were stimulated as described above with the appropriate supplements in the presence of [ 3 H]thymidine (0.25 mCi/ml, 1 mM) and incubated at 378C for 40 h. Cultures were then washed twice with phosphate buered saline (PBS) and incubated with 5% trichloroacetic acid at 48C for 30 min to remove acid-soluble label. After washing with methanol, samples were solubilised in 1 ml of 2% Na 2 CO 3 , 0.1 M NaOH, 1% SDS. The acid-insoluble radioactivity was determined by scintillation counting.
For Western blotting, cells were washed twice with PBS and lysed in 400 ml of SDS ± PAGE sample buer by scraping. Samples were boiled and resolved by SDS ± PAGE. The following percentage gels were used: pRb, 7%; all cyclins and cdks, 10%; all inhibitors, 12.5%. After electrophoresis, proteins were transfered to nitrocellulose membranes. Individual proteins were detected using speci®c antisera, the immunoreactive bands being visualised either by using horseradish peroxidase-conjugated secondary antibody and subsequent detection by enhanced chemiluminescence or by using 125 I-labelled protein A and autoradiography. Immunoprecipitation kinase assays were performed as described by Matsushime et al. (1994) . Northern blotting was performed by the formaldehyde method of Lehrach et al. (1977) . Probes were labelled by random priming (Feinberg and Vogelstein, 1984) .
Abbreviations cdk, cyclin-dependent kinase; DMEM, Dulbecco's modi®ed Eagle's medium; ECL, enhanced chemiluminescence; FBS, foetal bovine serum; IBMX, 3-isobutyl-1-methylxanthine; PAGE, polyacrylamide gel electrophoresis; PBS, phosphate buered saline; PDB, phorbol-12,13-dibutyrate; PKA, protein kinase A; PKC, protein kinase C; pRb, retinoblastoma protein; SDS, sodium dodecyl sulphate; TPA, 13, 
